MELISI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 606
EU - Europa 604
AS - Asia 160
AF - Africa 24
OC - Oceania 1
Totale 1.395
Nazione #
US - Stati Uniti d'America 592
DE - Germania 176
IT - Italia 176
UA - Ucraina 115
SG - Singapore 86
CN - Cina 65
NL - Olanda 48
FI - Finlandia 28
CI - Costa d'Avorio 24
IE - Irlanda 16
SE - Svezia 15
CA - Canada 13
FR - Francia 11
GB - Regno Unito 7
TR - Turchia 7
CZ - Repubblica Ceca 6
HU - Ungheria 4
AU - Australia 1
GR - Grecia 1
MX - Messico 1
PH - Filippine 1
PL - Polonia 1
TW - Taiwan 1
Totale 1.395
Città #
Chandler 165
Singapore 75
Jacksonville 58
Amsterdam 46
Santa Clara 32
Millbury 31
Princeton 27
Beijing 23
Naples 23
Boston 17
Nanjing 15
Wilmington 14
Napoli 10
Ottawa 10
Hebei 8
Norwalk 7
Bacoli 6
Ashburn 5
Brno 5
Houston 5
Montescaglioso 5
Nanchang 5
Contrada 4
Kronberg 4
Milan 4
Paris 4
Siena 4
Siracusa 4
Abidjan 3
Budapest 3
Falls Church 3
Kunming 3
Pomigliano D'arco 3
Potenza 3
Shenyang 3
Varedo 3
Andover 2
Busnago 2
Calgary 2
Caserta 2
Changsha 2
Dearborn 2
Dublin 2
Frankfurt am Main 2
Jiaxing 2
Rende 2
Salerno 2
Salò 2
Stilo 2
Alghero 1
Altavilla Silentina 1
Boardman 1
Bonn 1
Brisbane 1
Castellammare Di Stabia 1
Castelpagano 1
Catanzaro 1
Changchun 1
Dallas 1
Fairfield 1
Ferrara 1
Fisciano 1
Giugliano In Campania 1
Guangzhou 1
Hanover 1
Helsinki 1
Kastoria 1
Los Banos 1
Melito di Napoli 1
Monza 1
Mountain View 1
Munich 1
Nocera Superiore 1
Olsztyn 1
Orange 1
Oristano 1
Padova 1
Pozzuoli 1
Redwood City 1
Reggio Calabria 1
Rimini 1
Rome 1
San Antonio 1
San Mateo 1
Shanghai 1
Simi Valley 1
Solofra 1
Stella Cilento 1
Stockholm 1
Tianjin 1
Toronto 1
Trecase 1
Urbino 1
Woodbridge 1
Yellow Springs 1
Érd 1
Totale 713
Nome #
2-fenil-imidazo[1,2-B]piridazine ad attività analgesica ed antiepilettica 135
Derivati glicosilati della Nω-Nitro-L-Arginina come agenti antitumorali 105
Profarmaco galattosilato del ketorolac ad uso analgesico e antinfiammatorio con migliori caratteristiche farmacocinetiche e profilo tossicologico del farmaco di partenza 100
Composizioni farmaceutiche a base di zeoliti porose quali mezzi di rilascio di molecole farmacologicamente attive e relativo uso 71
Galactosilated dopamine increases attention without reducing activity in C57BL/6 mice 58
D-Galactose as a Vector for Prodrug Design. 57
Galactosylated dopamine enters into the brain, blocks mesocorticolimbic system and modulates activity and scanning time in naples high excitability rats 55
Galactosyl Derivative of N(omega)-Nitro-L-Arginine: Study of Antiproliferative Activity on Human Thyroid Follicular Carcinoma Cells 55
Synthetic Zeolites as a New Tool for Drug Delivery 54
Galactosyl derivatives of L-arginine and D-arginine: synthesis, stability, cell permeation, and nitric oxide production in pituitary GH3 cells 49
Profarmaco galattosilato della N-omega-nitro-L-arginina (nagal) ad uso analgesico ed antinfiammatorio con migliore caratteristiche farmacocinetiche e di tollerabilità del farmaco di partenza 49
Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect 49
Pharmaceutical compositions based on porous zeolites as release means of pharmacologically active molecules and relative use 48
Principi di analisi quantitativa dei medicinali 46
Sol-gel processing of anti-inflammatory entrapment in Silica, release kinetics and bioactivity 45
Multiple functionalization of fluorescent nanoparticles for specific biolabeling and drug delivery of dopamine. 40
Characterization, bioactivity and ampicillin release kinetics of TiO2 and TiO24SiO2 synthesized by sol-gel processing 39
Molecular pharmacology of the amiloride analog 3-amino-6-chloro-5-[(4-chloro-benzyl)amino]-n-[[(2,4-dimethylbenzyl)-amino]iminomethyl]-pyrazinecarboxamide (CB-DMB) as a pan inhibitor of the Na+-Ca2+ exchanger isoforms NCX1, NCX2, and NCX3 in stably transfected cells 39
Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations 37
Excitatory amino acids in the forebrain of the Naples high-excitability rats: Neurochemical and behavioural effects of subchronic d-aspartate and its diethyl ester prodrug 36
SEPARAZIONE E ANALISI DELLE PROPRIETA'FARMACOLOGICHE DELLE DIIDROPIRIDINE CHIRALI: VALUTAZIONE COMPARATIVA DEGLI ISOMERI OTTICI DELLA AMLODIPINA E DELLA LERCANIDIPINA. 35
Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations 32
T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacin 30
Arginine prodrugs with high therapeutic activity 28
null 27
Glycosyl derivatives of dopamine and L-dopa as anti-Parkinson prodrugs: synthesis, pharmacological activity and in vitro stability studies. 26
Galactosylated prodrugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug 22
The galactosylation of N(ω)-nitro-L-arginine enhances its anti-nocifensive or anti-allodynic effects by targeting glia in healthy and neuropathic mice 21
null 18
Totale 1.406
Categoria #
all - tutte 5.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.322


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 0 0 0 0 12 0 3 0 4 7 19 28
2020/2021211 9 18 26 17 21 29 25 8 16 3 35 4
2021/2022178 6 3 4 6 3 5 3 4 16 1 62 65
2022/2023346 32 45 8 34 42 34 12 26 51 46 14 2
2023/2024122 7 25 21 2 5 5 0 26 0 2 20 9
2024/2025133 45 56 1 3 28 0 0 0 0 0 0 0
Totale 1.406